Olympia Compounding Pharmacy dba Olympia Pharmacy

94 FDA enforcement actions

94 Total Recalls

0 Class I

90 Class II

4 Class III

Firm Details

Product Types: drug
States: FL

All Recalls

Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 05/09/2022 drug

Lack of assurance of sterility.
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

Failed Reconstitution time
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 04/04/2022 drug

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II: Risk 03/08/2022 drug

Sub Potent
Class III: Low Risk 03/08/2022 drug

Sub Potent
Class II: Risk 03/08/2022 drug

Super Potent and Failed Reconstitution Time
Class III: Low Risk 03/08/2022 drug

Super Potent
Class III: Low Risk 03/08/2022 drug

Sub Potent
Class III: Low Risk 03/08/2022 drug

Sub Potent
Class II: Risk 03/08/2022 drug

Product found to be Sub Potent or Exceeded reconstitution time

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.